Can Sitagliptin reduce the risk of cardiovascular complications in high-risk diabetic patients, and how does it address inflammation and endothelial dysfunction?
Sunil JoshiExplorer
Can Sitagliptin reduce the risk of cardiovascular complications in high-risk diabetes?
Share